Lv1
20 积分 2025-02-26 加入
Cost-effectiveness analysis of atezolizumab plus chemotherapy in the first-line treatment of extensive-stage small-cell lung cancer
2个月前
已完结
Covid-19: preparedness, decentralisation, and the hunt for patient zero
3个月前
已完结
Advances in systemic therapy for non-small cell lung cancer
4个月前
已完结
Cancer will cost the world $25 trillion over next 30 years
4个月前
已完结
Non-small-cell lung cancer
4个月前
已完结
Health state utilities in non–small cell lung cancer: An international study
5个月前
已完结
Comparison of the efficacy and safety of domestically produced tislelizumab, camrelizumab, and imported pembrolizumab in the treatment of advanced NSCLC: a real-world retrospective study
5个月前
已完结
The diverse functions of the PD1 inhibitory pathway
6个月前
已完结
Cost-effectiveness of Laparoscopic vs Open Gastrectomy for Gastric Cancer
6个月前
已完结
Adding lurbinectedin to maintenance therapy improves outcomes in ES-SCLC
6个月前
已完结
皖公网安备34019202002308
